CLOs on the Move

Allos Therapeutics

www.allos.com

 
Allos Therapeutics, Inc. is a biopharmaceutical company that is focused on developing and commercializing small molecule drugs for the treatment of cancer. The CompanyÍs lead product candidate, pralatrexate (PDX) an antifolate, is in Phase II trial in
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Pfenex

We are a clinical stage development and licensing biotechnology company focused on leveraging our Pfenex Expression Technologyâ„¢ platform to develop and improve protein therapies for unmet patient needs.

Saneron CCEL Therapeutics

Saneron CCEL Therapeutics is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RNAimmune

RNAimmune is a biotechnology startup in the field of messenger RNA (mRNA) technology with more than 20 years expertise in handling and optimizing this versatile molecule for medical purposes. The principle of RNAimmune`s proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. The company applies its technologies for the development of cancer therapies, antibody therapies, the treatment of rare diseases, and prophylactic vaccines.

Afrivax

Afrivax is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Interface Biologics

Interface Biologics Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.